Immune-Inflammatory Responses in Atherosclerosis: The Role of Myeloid Cells

Ross, 1999, Atherosclerosis—An inflammatory disease, N. Engl. J. Med., 340, 115, 10.1056/NEJM199901143400207

Alipov, 2017, Chemical composition of circulating native and desialylated low density lipoprotein: What is the difference?, Vessel Plus, 1, 107

Wong, 2012, The biological role of inflammation in atherosclerosis, Can. J. Cardiol., 28, 631, 10.1016/j.cjca.2012.06.023

Gimbrone, 2013, Vascular endothelium, hemodynamics, and the pathobiology of atherosclerosis, Cardiovasc. Pathol., 22, 9, 10.1016/j.carpath.2012.06.006

Kasikara, 2018, The role of non-resolving inflammation in atherosclerosis, J. Clin. Investig., 128, 2713, 10.1172/JCI97950

Galkina, 2009, Immune and inflammatory mechanisms of atherosclerosis, Annu. Rev. Immunol., 27, 165, 10.1146/annurev.immunol.021908.132620

Gerrity, 1979, Dietary induced atherogenesis in swine. Morphology of the intima in prelesion stages, Am. J. Pathol., 95, 775

Galkina, 2007, Leukocyte influx in atherosclerosis, Curr. Drug Targets, 8, 1239, 10.2174/138945007783220650

Haidari, 2006, Low-grade chronic inflammation in regions of the normal mouse arterial intima predisposed to atherosclerosis, J. Exp. Med., 203, 2073, 10.1084/jem.20060245

Lessner, 2002, Atherosclerotic lesions grow through recruitment and proliferation of circulating monocytes in a murine model, Am. J. Pathol., 160, 2145, 10.1016/S0002-9440(10)61163-7

Lord, 1999, Clustering of dendritic cells in athero-prone areas of the aorta, Atherosclerosis, 146, 197

Strieter, 1989, Monocyte chemotactic protein gene expression by cytokine-treated human fibroblasts and endothelial cells, Biochem. Biophys. Res. Commun., 162, 694, 10.1016/0006-291X(89)92366-8

Pober, 1984, Interactions of T lymphocytes with human vascular endothelial cells: Role of endothelial cells surface antigens, Immunobiology, 168, 483, 10.1016/S0171-2985(84)80132-1

Bobryshev, 2006, Monocyte recruitment and foam cell formation in atherosclerosis, Micron, 37, 208, 10.1016/j.micron.2005.10.007

Huo, 2009, P-selectin glycoprotein ligand-1 plays a crucial role in the selective recruitment of leukocytes into the atherosclerotic arterial wall, Trends Cardiovasc. Med., 19, 140, 10.1016/j.tcm.2009.07.006

Randolph, 2008, Antigen presentation by monocytes and monocyte-derived cells, Curr. Opin. Immunol., 20, 52, 10.1016/j.coi.2007.10.010

Hatakeyama, 1994, The murine c-fgr gene product associated with Ly6C and p70 integral membrane protein is expressed in cells of a monocyte/macrophage lineage, Proc. Natl. Acad. Sci. USA, 91, 3458, 10.1073/pnas.91.8.3458

Lauvau, 2014, Inflammatory monocyte effector mechanisms, Cell. Immunol., 291, 32, 10.1016/j.cellimm.2014.07.007

Fong, 1998, Fractalkine and CX3CR1 mediate a novel mechanism of leukocyte capture, firm adhesion, and activation under physiologic flow, J. Exp. Med., 188, 1413, 10.1084/jem.188.8.1413

Tacke, 2007, Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques, J. Clin. Investig., 117, 185, 10.1172/JCI28549

Auffray, 2007, Monitoring of blood vessels and tissues by a population of monocytes withpatrolling behavior, Science, 317, 666, 10.1126/science.1142883

Thomas, 2015, Nonclassical patrolling monocyte function in the vasculature, Arterioscler. Thromb. Vasc. Biol., 35, 1306, 10.1161/ATVBAHA.114.304650

Potteaux, 2008, Combined inhibition of CCL2, CX3CR1, and CCR5 abrogates Ly6Chi and Ly6Clo monocytosis and almost abolishes atherosclerosis in hypercholesterolemic mice, Circulation, 117, 1649, 10.1161/CIRCULATIONAHA.107.745091

Ilhan, 2015, Atherosclerosis and the role of immune cells, World J. Clin. Cases, 3, 345, 10.12998/wjcc.v3.i4.345

Funk, 1993, Lipopolysaccharide stimulation of RAW 264.7 macrophages induces lipid accumulation and foam cell formation, Atherosclerosis, 98, 67, 10.1016/0021-9150(93)90224-I

Lee, 2008, A combination of Lox-1 and Nox1 regulates TLR9-mediated foam cell formation, Cell. Signal., 20, 2266, 10.1016/j.cellsig.2008.08.022

Higashimori, 2011, Role of toll-like receptor 4 in intimal foam cell accumulation in apolipoprotein E-deficient mice, Arterioscler. Thromb. Vasc. Biol., 31, 50, 10.1161/ATVBAHA.110.210971

Cole, 2010, The expression and functions of toll-like receptors in atherosclerosis, Mediat. Inflamm., 2010, 393946, 10.1155/2010/393946

Seneviratne, 2012, Toll-like receptors and macrophage activation in atherosclerosis, Clin. Chim. Acta, 413, 3, 10.1016/j.cca.2011.08.021

Febbraio, 2000, Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice, J. Clin. Investig., 105, 1049, 10.1172/JCI9259

Moore, 2005, Loss of receptor-mediated lipid uptake via scavenger receptor A or CD36 pathways does not ameliorate atherosclerosis in hyperlipidemic mice, J. Clin. Investig., 115, 2192, 10.1172/JCI24061

Kuchibhotla, 2008, Absence of CD36 protects against atherosclerosis in ApoE knock-out mice with no additional protection provided by absence of scavenger receptor A I/II, Cardiovasc. Res., 78, 185, 10.1093/cvr/cvm093

Kataoka, 1999, Expression of lectinlike oxidized low-density lipoprotein receptor-1 in human atherosclerotic lesions, Circulation, 99, 3110, 10.1161/01.CIR.99.24.3110

Yoshida, 1998, Identification of the lectin-like receptor for oxidized low-density lipoprotein in human macrophages and its potential role as a scavenger receptor, Biochem. J., 334, 9, 10.1042/bj3340009

Kume, 2001, Lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) in atherogenesis, Trends Cardiovasc. Med., 11, 22, 10.1016/S1050-1738(01)00079-2

Schaeffer, 2009, LOX-1 augments oxLDL uptake by lysoPC-stimulated murine macrophages but is not required for oxLDL clearance from plasma, J. Lipid. Res., 50, 1676, 10.1194/jlr.M900167-JLR200

Inoue, 2005, Overexpression of lectin-like oxidized low-density lipoprotein receptor-1 induces intramyocardial vasculopathy in apolipoprotein E-null mice, Circ. Res., 97, 176, 10.1161/01.RES.0000174286.73200.d4

Mehta, 2007, Deletion of LOX-1 reduces atherogenesis in LDLR knockout mice fed high cholesterol diet, Circ. Res., 100, 1634, 10.1161/CIRCRESAHA.107.149724

Chistiakov, 2015, Macrophage phenotypic plasticity in atherosclerosis: The associated features and the peculiarities of the expression of inflammatory genes, Int. J. Cardiol., 184, 436, 10.1016/j.ijcard.2015.03.055

Butcher, 2014, The dynamic lives of macrophage and dendritic cell subsets in atherosclerosis, Ann. N. Y. Acad. Sci., 1319, 19, 10.1111/nyas.12392

Zhang, S., Kim, C.C., Batra, S., McKerrow, J.H., and Loke, P. (2010). Delineation of diverse macrophage activation programs in response to intracellular parasites and cytokines. PLoS Negl. Trop. Dis., 4.

Benderitter, 2013, Flagellin or lipopolysaccharide treatment modified macrophage populations after colorectal radiation of rats, J. Pharmacol. Exp. Ther., 346, 75, 10.1124/jpet.113.204040

Mantovani, 2004, The chemokine system in diverse forms of macrophage activation and polarization, Trends Immunol., 25, 677, 10.1016/j.it.2004.09.015

Martinez, 2008, Macrophage activation and polarization, Front. Biosci., 13, 453, 10.2741/2692

Zizzo, 2012, Efficient clearance of early apoptotic cells by human macrophages requires M2c polarization and MerTK induction, J. Immunol., 189, 3508, 10.4049/jimmunol.1200662

Ramanathan, 2003, An angiogenic switch in macrophages involving synergy between Toll-like receptors 2, 4, 7, and 9 and adenosine A(2A) receptors, Am. J. Pathol., 163, 711, 10.1016/S0002-9440(10)63698-X

Ferrante, 2013, The adenosine-dependent angiogenic switch of macrophages to an M2-like phenotype is independent of interleukin- 4 receptor alpha (IL-4Ralpha) signaling, Inflammation, 36, 921, 10.1007/s10753-013-9621-3

Gleissner, 2010, CXC chemokine ligand 4 induces a unique transcriptome in monocyte-derived macrophages, J. Immunol., 184, 4810, 10.4049/jimmunol.0901368

Erbel, 2015, CXCL4-induced plaque macrophages can be specifically identified by co-expression of MMP7+S100A8+ in vitro and in vivo, Innate Immun., 21, 255, 10.1177/1753425914526461

Gleissner, 2012, Macrophage phenotype modulation by CXCL4 in atherosclerosis, Front. Physiol., 3, 1, 10.3389/fphys.2012.00001

Kadl, 2010, Identification of a novel macrophage phenotype that develops in response to atherogenic phospholipids via Nrf2, Circ. Res., 107, 737, 10.1161/CIRCRESAHA.109.215715

Colin, 2015, Macrophage subsets in atherosclerosis, Nat. Rev. Cardiol., 12, 10, 10.1038/nrcardio.2014.173

Boyle, 2009, Coronary intraplaque hemorrhage evokes a novel atheroprotective macrophage phenotype, Am. J. Pathol., 174, 1097, 10.2353/ajpath.2009.080431

Finn, 2012, Hemoglobin directs macrophage differentiation and prevents foam cell formation in human atherosclerotic plaques, J. Am. Coll. Cardiol., 59, 166, 10.1016/j.jacc.2011.10.852

Boyle, 2012, Activating transcription factor 1 directs Mhem atheroprotective macrophages through coordinated iron handling and foam cell protection, Circ. Res., 110, 20, 10.1161/CIRCRESAHA.111.247577

Philippidis, 2004, Hemoglobin scavenger receptor CD163 mediates interleukin-10 release and heme oxygenase-1 synthesis: Antiinflammatory monocyte-macrophage responses in vitro, in resolving skin blisters in vivo, and after cardiopulmonary bypass surgery, Circ. Res., 94, 119, 10.1161/01.RES.0000109414.78907.F9

Groh, 2018, Monocyte and macropjhage immunometabolism in atherosclerosis, Semin. Immunopathol., 40, 203, 10.1007/s00281-017-0656-7

West, 2011, TLR signaling augments macrophage bactericidal activity through mitochondrial ROS, Nature, 472, 476, 10.1038/nature09973

Bonacina, 2019, Immunometabolic function of cholesterol in cardiovascular disease and beyond, Cardiovasc. Res., 115, 1393, 10.1093/cvr/cvz127

Joosten, 2019, Immunometabolism orchestrates training of innate immunity in atherosclerosis, Cardiovasc. Res., 115, 1416, 10.1093/cvr/cvz107

Siasos, 2018, Mitochondria and cardiovascular diseases-from pathophysiology to treatment, Ann. Transl. Med., 6, 256, 10.21037/atm.2018.06.21

Bobryshev, 1995, Ultrastructural recognition of cells with dendritic cell morphology in human aortic intima. Contacting interactions of Vascular Dendritic Cells in athero-resistant and athero-prone areas of the normal aorta, Arch. Histol. Cytol., 58, 307, 10.1679/aohc.58.307

Wigren, 2012, Lymphocytes in atherosclerosis, Clin. Chim. Acta, 413, 1562, 10.1016/j.cca.2012.04.031

Chistiakov, 2015, Myeloid dendritic cells: Development, functions, and role in atherosclerotic inflammation, Immunobiology, 220, 833, 10.1016/j.imbio.2014.12.010

Kadowaki, 2001, Subsets of human dendritic cell precursors express different toll-like receptors and respond to different microbial antigens, J. Exp. Med., 194, 863, 10.1084/jem.194.6.863

Chistiakov, 2014, Plasmacytoid dendritic cells: Development, functions, and role in atherosclerotic inflammation, Front. Physiol., 5, 279

Penna, 2002, Differential migration behavior and chemokine production by myeloid and plasmacytoid dendritic cells, Hum. Immunol., 63, 1164, 10.1016/S0198-8859(02)00755-3

Dzionek, 2000, BDCA-2, BDCA-3, and BDCA-4: Three markers for distinct subsets of dendritic cells in human peripheral blood, J. Immunol., 165, 6037, 10.4049/jimmunol.165.11.6037

Jongbloed, 2010, Human CD141+(BDCA-3) + dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens, J. Exp. Med., 207, 1247, 10.1084/jem.20092140

Legein, 2013, Inflammation and immune system interactions in atherosclerosis, Cell. Mol. Life Sci., 70, 3847, 10.1007/s00018-013-1289-1

Dopheide, 2007, Monocyte-derived dendritic cells of patients with coronary artery disease show an increased expression of costimulatory molecules CD40, CD80 and CD86 in vitro, Coron. Artery Dis., 18, 523, 10.1097/MCA.0b013e3282eff1ad

Wang, 2008, Toll-like receptor-4 and mitogen-activated protein kinase signal system are involved in activation of dendritic cells in patients with acute coronary syndrome, Immunology, 125, 122, 10.1111/j.1365-2567.2008.02827.x

Ghattas, 2013, Monocytes in coronary artery disease and atherosclerosis: Where are we now?, J. Am. Coll. Cardiol., 62, 1541, 10.1016/j.jacc.2013.07.043

Sage, 2014, Adaptive (T and B cells) immunity and control by dendritic cells in atherosclerosis, Circ. Res., 114, 1640, 10.1161/CIRCRESAHA.114.302761

Manthey, 2012, Auto-antigenic protein-DNA complexes stimulate plasmacytoid dendritic cells to promote atherosclerosis, Circulation, 125, 1673, 10.1161/CIRCULATIONAHA.111.046755

Niessner, 2006, Pathogen-sensing plasmacytoid dendritic cells stimulate cytotoxic T-cell function in the atherosclerotic plaque through interferon-alpha, Circulation, 114, 2482, 10.1161/CIRCULATIONAHA.106.642801

Anand, 2011, Role of the nlrp3 inflammasome in microbial infection, Front. Microbiol., 2, 12, 10.3389/fmicb.2011.00012

Sozzani, 2010, Trafficking properties of plasmacytoid dendritic cells in health and disease, Trends Immunol., 31, 270, 10.1016/j.it.2010.05.004

Butcher, 2012, Phenotypic and functional heterogeneity of macrophages and dendritic cell subsets in the healthy and atherosclerosis-prone aorta, Front. Physiol., 3, 44, 10.3389/fphys.2012.00044

Bobryshev, 1998, Mapping of vascular dendritic cells in atherosclerotic arteries suggests their involvement in local immune inflammatory reaction, Cardiovasc. Res., 37, 799, 10.1016/S0008-6363(97)00229-0

Koltsova, 2012, Dynamic T cell-APC interactions sustain chronic inflammation in atherosclerosis, J. Clin. Investig., 122, 3114, 10.1172/JCI61758

Coutant, 2001, Oxidized low-density lipoprotein promotes mature dendritic cell transition from differentiating monocyte, J. Immunol., 167, 3785, 10.4049/jimmunol.167.7.3785

Paulson, 2010, Resident intimal dendritic cells accumulate lipid and contribute to the initiation of atherosclerosis, Circ. Res., 106, 383, 10.1161/CIRCRESAHA.109.210781

Weber, 2011, CCL17-expressing dendritic cells drive atherosclerosis by restraining regulatory T cell homeostasis in mice, J. Clin. Investig., 121, 2898, 10.1172/JCI44925

Maldonado, 2010, How tolerogenic dendritic cells induce regulatory T cells, Adv. Immunol., 108, 111, 10.1016/B978-0-12-380995-7.00004-5

Choi, 2011, Flt3 signaling-dependent dendritic cells protect against atherosclerosis, Immunity, 35, 819, 10.1016/j.immuni.2011.09.014

Chistiakov, 2013, Regulatory T cells in atherosclerosis and strategies to induce the endogenous atheroprotective immune response, Immunol Lett., 151, 10, 10.1016/j.imlet.2013.01.014

Lievens, 2013, Abrogated transforming growth factor beta receptor II (TGFβRII) signalling in dendritic cells promotes immune reactivity of T cells resulting in enhanced atherosclerosis, Eur. Heart J., 34, 3717, 10.1093/eurheartj/ehs106

Fife, 2009, Interactions between PD-1 and PD-L1 promote tolerance by blocking the TCR-induced stop signal, Nat. Immunol., 10, 1185, 10.1038/ni.1790

Heitger, 2011, Regulation of expression and function of IDO in human dendritic cells, Curr. Med. Chem., 18, 2222, 10.2174/092986711795656018

Fallarino, 2005, Ligand and cytokine dependence of the immunosuppressive pathway of tryptophan catabolism in plasmacytoid dendritic cells, Int. Immunol., 17, 1429, 10.1093/intimm/dxh321

Daissormont, 2011, Plasmacytoid dendritic cells protect against atherosclerosis by tuning T-cell proliferation and activity, Circ. Res., 109, 1387, 10.1161/CIRCRESAHA.111.256529

Ovchinnikova, 2014, Mycobacterium bovis BCG killed by extended freeze-drying induces an immunoregulatory profile and protects against atherosclerosis, J. Intern. Med., 275, 49, 10.1111/joim.12127